Control Bionics Limited (ASX:CBL)
Australia · Delayed Price · Currency is AUD 0.0690
-0.0010 (-1.43%)
Jul 17, 2026, 3:50 PM AEST
Control Bionics Market Cap
Control Bionics has a market cap or net worth of 28.43 million as of July 17, 2026. Its market cap has increased by 129.72% in one year.
Market Cap
28.43M
Enterprise Value
25.61M
Revenue
6.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
ChartMarket Cap Chart
Since December 7, 2020, Control Bionics's market cap has decreased from 98.33M to 28.43M, a decrease of -71.09%. That is a compound annual growth rate of -19.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 28.43M | 15.48% |
| Dec 31, 2025 | 24.61M | 62.80% |
| Dec 31, 2024 | 15.12M | 126.88% |
| Dec 29, 2023 | 6.66M | -55.36% |
| Dec 30, 2022 | 14.93M | -59.58% |
| Dec 30, 2021 | 36.94M | -52.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cleo Diagnostics | 49.95M |
| OncoSil Medical | 45.43M |
| Compumedics | 44.95M |
| HeraMED | 43.98M |
| Nova Eye Medical | 32.76M |
| CleanSpace Holdings | 29.59M |
| Micro-X | 26.18M |
| Memphasys | 24.70M |